2BBBullish & Bearish
Health Care

SAB Biotherapeutics, Inc. (SABS) Stock Score & Signals

SAB Biotherapeutics, Inc. (SABS) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 23 out of 100.

2BB score and signals

SAB Biotherapeutics, Inc.’s current 2BB score is 23 out of 100, built from the signal categories below.

SignalScoreReading
Activity12Very Low
Momentum50Stable
Financial strength48Normal
Quality80Very Strong

Company facts

HeadquartersMiami Beach, Florida, United States
Founded2014
Employees86
52-week range$1.72 – $6.60

Recent earnings

Report dateEPS actualEPS estimateRevenue actualRevenue estimate
2027-03-08—-0.2608—$0.00
2026-11-11—-0.2782—$0.00
2026-08-06—-0.2952—$0.00
2026-05-07—-0.2171—$0.00